Image

PARTial BREast RECONstruction With Chest Wall Perforator Flap

PARTial BREast RECONstruction With Chest Wall Perforator Flap

Recruiting
18 years and older
Female
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

The goal of this observational study is to ascertain the outcomes following partial breast reconstruction using chest wall perforator flaps after breast conservation surgery.

Description

The Main Outcomes and Measures are:

  1. Patient Demographics and Tumour characteristics
    1. Patient demographics: age, body mass index (BMI), comorbidities
    2. Preoperative tumour characteristics and location influencing surgical planning
  2. Treatment characteristics
    1. Surgical: operative data, including flap types and distribution
    2. Oncological: systemic therapies (adjuvant and neoadjuvant), radiotherapy

Eligibility

Inclusion Criteria:

  • Patients undergoing partial breast reconstruction using CWPF for primary breast cancer
  • Delayed correction of breast deformity following previous BCS
  • Each surgeon is to have performed a minimum of 10 CWPFs
  • Each centre anticipates completing a minimum of 10/year

Exclusion Criteria:

  • Patients undergoing volume displacement BCS
  • Patients undergoing mastectomy +/- immediate breast reconstruction

Study details
    Breast Cancer Early Stage Breast Cancer (Stage 1-3)
    Breast Carcinoma
    Breast Neoplasms
    Breast Surgery
    Breast Reconstruction Surgery

NCT06728527

Cambridge University Hospitals NHS Foundation Trust

7 September 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.